Financials
- Market Capitalization 2.13 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.34
ratio cours/chiffre d'affaires
11.93
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1941 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 20.86 USD | -3.38% | +12.39% | +34.23% | +15.57% | 2.20 B USD | ||
| 1948 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -1.69% | +7.88% | +36.55% | 2.17 B USD | ||
| 1972 | VCEL Vericel Corporation - Common Stock | 40.95 USD | -0.56% | -4.05% | -16.26% | +12.65% | 2.10 B USD | ||
| 1975 | ADMA ADMA Biologics Inc - Common Stock | 9.34 USD | -1.48% | -4.69% | +9.62% | -45.35% | 2.09 B USD |